Find all relevant presentations and publications for each of our programs. From review papers to preclinical posters and clinical data presentations at medical conferences.
… Retinal Cell and Gene Therapy Innovation Summit For more information visit the conference … ProQR to present at the Retinal Cell and Gene Therapy Innovation Summit. …
… immune response.” What does your current role, Chief Innovation Officer, entail? “My responsibility is the … to (our CEO) Daniel that he wants to invest so much in innovation. About one third of the company is dedicated to …
There are currently around 160 people working at ProQR, but that wasn’t always the case. When Hee Lam Chan joined in 2013, she was only employee number six. As a result, she has seen the company grow and develop.
… technology development. ProQR’s Sr. Vice President Innovation makes his point about the promise of Axiomer® … to become therapeutics. Gerard Platenburg, our Chief Innovation Officer, and myself believed we could pull off …
… ProQR Announces R&D Day and Provides Update on Innovation Portfolio First Investor R&D Day on March 14, 2016 … amaurosis (LCA), today presents an update on the innovation pipeline and announces an R&D day for investors. …
… ProQR Receives € 4.7 million in Innovation Credit from Dutch Government for QR-110 for LCA10 … only by market approval of QR-110. Innovation credit (“Innovatiekrediet”) The Innovation Credit is awarded by the …
… ProQR to Present at the Retinal Cell and Gene Therapy Innovation Summit and the Association for Research in Vision … at the 7th Annual Retinal Cell and Gene Therapy Innovation Summit being held Friday, April 29, 2022 and the … U.S. Presentations at the Retinal Cell and Gene Therapy Innovation Summit Presentation title: AON treatment for …
… market and will hopefully contribute to bringing future innovations into the industry. Leiden student learning about … ProQR provided the students with tours of our innovative laboratories in Leiden, including the R&D, CMC and …
